Title: Mary Psilogenis: Innovator in Nasal Administration for Delayed Onset Emesis
Introduction
Mary Psilogenis is a notable inventor based in Italy, recognized for her contributions to the field of medical treatments. She has developed innovative methods aimed at improving patient care, particularly in the management of delayed onset emesis. Her work reflects a commitment to enhancing therapeutic approaches through scientific research and development.
Latest Patents
Mary Psilogenis holds a patent for the invention titled "Nasal Administration Of Agents For Treatment Of Delayed Onset Emesis." This invention focuses on a method for the prophylactic management of delayed emesis using metoclopramide nasal spray. Although she currently has 0 patents, her work in this area demonstrates her potential for future innovations.
Career Highlights
Mary is associated with Ribogene, Inc., where she applies her expertise in developing novel therapeutic solutions. Her role at the company allows her to collaborate with other professionals in the field, contributing to advancements in medical treatments.
Collaborations
Due to space constraints, the details of her collaborations will not be included.
Conclusion
Mary Psilogenis is an innovative inventor whose work in nasal administration for delayed onset emesis showcases her dedication to improving medical treatments. Her contributions to the field highlight the importance of ongoing research and development in healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.